# FDA Inspection 1069242 - MiMedx Group, Inc. - September 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/c5cc33c5-b52b-4226-ad64-70d6e22ad833
Source feed: FDA_Inspections

> FDA Inspection 1069242 for MiMedx Group, Inc. on September 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069242
- Company Name: MiMedx Group, Inc.
- Inspection Date: 2018-09-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1198732 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/495a9599-303b-4b00-9b51-d82febc2ac7a)
- [FDA Inspection 1198732 - 2023-03-02](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/0792a015-f055-450b-8494-95ad202f466e)
- [FDA Inspection 1112843 - 2019-12-12](https://www.keypedia.com/records/fda_inspections/mimedx-group-inc/1435ccd2-4ab5-4cff-850f-38e6beb19f63)

Company: https://www.keypedia.com/companies/mimedx-group-inc/48cc856a-f21d-4488-bbbd-4428f7bf1308

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d